TRPHARM, in line with its original patented drug development goal and global vision, has redefined the name of its Medical Unit to Medical and Scientific Development Unit and the title of Associate Professor Dr. Tolga Tunçel, who serves as the Medical Director to Medical and Scientific Development Director.
Under the leadership of Tolga Tunçel, MD, Assoc Prof of M. Oncology, the unit plays a significant role in delivering products to patients, particularly in the areas of rare diseases, eye health, child health, and medical aesthetics, in Turkey and the MENA region.
